-
Sector Analysis
Seasonal Influenza Vaccines – US Drug Forecast and Market Analysis to 2025
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. The US will experience solid growth in...
-
Sector Analysis
Seasonal Influenza Vaccines – Japan Drug Forecast and Market Analysis to 2025
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. The projected drivers for growth of the...
-
Sector Analysis
Seasonal Influenza Vaccines – 5EU Drug Forecast and Market Analysis to 2025
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza. A quadrivalent formulation of Intanza Intradermal is...
-
Sector Analysis
EpiCast Report: Seasonal Influenza – Epidemiology Forecast to 2025
Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses resulting in mild to severe influenza-like illness. Seasonal influenza affects persons of all ages. Each year, between 5% and 15% of the world's population is affected by seasonal influenza (WHO, 2013). Complications of influenza include pneumonia, bronchitis, ear infections, sinus infections, and worsening of chronic medical conditions such as congestive heart failure, asthma, or diabetes. Vaccination has been shown to reduce influenza morbidity and mortality...
-
Sector Analysis
EpiCast Report: Hepatitis C Virus – Epidemiology Forecast to 2025
Hepatitis C is a blood-borne liver disease caused by the hepatitis C virus (HCV). HCV can cause both acute and chronic hepatitis infection. According to the World Health Organization (WHO), an estimated 130–150 million individuals worldwide are affected with chronic HCV and about 500,000 people died of HCV-related conditions, including liver cirrhosis and hepatocellular carcinoma (HCC), in 2010 (Lozano et al., 2012; WHO, 2015). In the 9MM, GlobalData epidemiologists forecast that the anti-HCV+ total prevalent cases will increase from 19,842,780...
-
Product Insights
Helminthiasis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Helminthiasis Global Clinical Trials Review, H2, 2016" provides an overview of Helminthiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Helminthiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Cholera Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Cholera Global Clinical Trials Review, H2, 2016" provides an overview of Cholera clinical trials scenario. This report provides top line data relating to the clinical trials on Cholera. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Trypanosomiasis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, H2, 2016" provides an overview of Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Trypanosomiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Candidiasis Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Candidiasis Global Clinical Trials Review, H2, 2016" provides an overview of Candidiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Candidiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Abscess Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Abscess Global Clinical Trials Review, H2, 2016" provides an overview of Abscess clinical trials scenario. This report provides top line data relating to the clinical trials on Abscess. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.